NS-229 is under clinical development by Nippon Shinyaku and currently in Phase II for Granulomatosis with Polyangiitis (Wegener’s Granulomatosis). According to GlobalData, Phase II drugs for ...

Wegener’s granulomatosis (WG) is a systemic inflammatory disease whose histopathologic features often include necrosis, granuloma formation, and vasculitis of small-to-medium-sized vessels. We report ...

Wegener's granulomatosis/granulomatosis with polyangiitis is a fatal disease if left untreated, and the natural history is for only 50% of patients to survive 5 ...

The arteritic category comprises less than 5% of CRAO cases and has been reported in association with giant cell arteritis (GCA), anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis (AAV ...